Back to search

Ireland· IE-PA-PA0540/160/001

Stilnoct 5 mg Film Coated Tablets

A zolpidem product containing zolpidem tartrate, registered in Ireland by Sanofi-Aventis Ireland Limited T/A SANOFI. The same ATC class is registered in 18 of our 19 countries.

ATC N05CF02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedStilnoct 5 mg Film Coated TabletsATCN05CF02REGISTER NO.IE-PA-PA0540/160/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Zolpidem is registered in 18 of 19 countries.

Countries holding a registration under ATC N05CF02 (zolpidem), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 10 of them publish a price we can compare per daily dose

Zolpidem · ATC N05CF02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zolpidem costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.11 in Spain to $0.89 in Switzerland — a ×8.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Zolpidem · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.89
  • FR France$0.18
  • ES Spain$0.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Zolpidem tartrate
Manufacturer
Sanofi-Aventis Ireland Limited T/A SANOFI
Country
Ireland (IE)
ATC code
N05CF02
ATC class
Zolpidem
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0540/160/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

392 interactions on record for zolpidem.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zolpidem · interactions on record

392 records

  • 4 severe
  • 129 moderate
  • 1 minor
  • 240 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zolpidem in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zolpidem products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ivadal, Mondeal
  • Belgium · Stilnoct, Zolpeduar
  • Bulgaria · Адорма, Золcaна
  • Cyprus · Stilnox
  • Czechia · Adorma, Hypnogen
  • Germany · Bikalm, Stilnox
  • Denmark · Stilnoct, Zolpidem Actavis
  • Estonia · Hypnogen, Stilnox
  • Spain · Dagan, Dalparan
  • Finland · Somnor, Stella
  • France · Oratika, Stilnox
  • United Kingdom (Northern Ireland) · Zalzo, Zolpidem
  • Greece · Hypnonorm, Oniria
  • Croatia · Lunata, Sanval
  • Hungary · Hypnogen, Sanval
  • Iceland · Edluar, Stilnoct
  • Italy · Belirem, Nottem
  • Lithuania · Hypnogen, Stilnox
  • Luxembourg · Stilnoct, Zolpeduar
  • Latvia · Hypnogen, Stilnox
  • Malta · Stilnox, Zolpidem Aurobindo
  • Netherlands · Zolpidem Tartrate Ratiopharm, Zolpidemtartraat Aurobindo
  • Norway · Stilnoct, Zolpidem Actavis
  • Poland · Apozolpin, Hypnogen
  • Portugal · Stilnox, Zolpidem Aurovitas
  • Romania · Stilnox, Zadobra
  • Sweden · Edluar, Stilnoct
  • Slovenia · Perluna, Sanval
  • Slovakia · Hypnogen, Sanval

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed45671b-c950-4de0-ad04-b9155b4ad57e
GET /v1/drugs/ed45671b-c950-4de0-ad04-b9155b4ad57e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N05CF",
    "N05CF02"
  ],
  "strength": null,
  "pa_number": "PA0540/160/001",
  "substances": [
    "Zolpidem tartrate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "25/02/1993",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0135-001-003"
}

See everything about zolpidem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.